US5840059A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Therapeutic and diagnostic agent delivery
Assignee: Columbia University
•
Filing: 1995-06-07
•
Granted: 1998-11-24
•
Expires: 2015-06-07
Abstract
Abstract A system for treating a patient's heart which comprises a means to form channels in the heart wall and a means to deliver a therapeutic or diagnostic agent into the channels. Additionally, the system may comprise a way to retain the agent within the channels for a useful period of time. The system may be configured to be introduced percutaneously or intraoperatively. The system generally comprises an elongated, flexible lasing transmission catheter that emits laser radiation and has delivery lumen opening at the distal end. Practice of the invention comprises forming channels in the heart wall and delivering a therapeutic or diagnostic agent into the channel. Gene therapy agents of this invention comprise vectors for transferring genetic information to the heart tissue in vivo or harvested cells which have been genetically engineered in vitro. Additionally, the invention may comprise retaining the agent within the channels, for example, by incorporating the agent in a viscous carrier.
Inventors
- 👤 Keith L. March
- 👤 Michael Aita
- 👤 Randy Kesten
- 👤 Craig Smith
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:33
CPC Classifications
A; A61; A61M; A61M37/00; A61B; A61B18/00; A61B18/18; A61B18/20; A61B18/22; A61B18/24; A61B17/00; A61B17/00234; A61B2017/00238; A61B2017/00243; A61B2017/00247; A61B17/22; A61B2017/22082; A61B2018/00315; A61B2018/00345; A61B2018/00351; A61B2018/00392; A61M2210/00; A61M2210/12; A61M2210/125
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
104 words
A method for treating a patient's heart comprising the steps of: a) providing a tissue ablation means to form a channel within a wall of the patient's heart which includes a myocardial layer and means to deliver a therapeutic or diagnostic agent into a channel formed by the channel forming means; b) positioning the channel forming means against a desired region of the heart wall; c) activating the channel forming means to form a channel in the wall of the patient's heart; d) withdrawing at least in part the channel forming means from the thus formed channel, e) delivering the agent into the channel.
Claim 2
Independent Claim
104 words
A method for treating a patient's heart comprising the steps of: a) providing a tissue ablation means to form a channel within a wall of the patient's heart which includes a myocardial layer and means to deliver a therapeutic or diagnostic agent into a channel formed by the channel forming means; b) positioning the channel forming means against a desired region of the heart wall; c) activating the channel forming means to form a channel in the wall of the patient's heart; d) withdrawing at least in part the channel forming means from the thus formed channel, e) delivering the agent into the channel.
Claim 3
Dependent Claim
26 words
The method of claim 1, wherein the step of positioning the channel forming means comprises advancing the channel forming means intravascularly to the patient's left ventricle.
Claim 4
Dependent Claim
16 words
The method of claim 2, further comprising the step of retaining the agent within a channel.
Claim 5
Dependent Claim
29 words
The method of claim 3, wherein an inflatable occlusion means on a distal portion of a delivery catheter is inserted into the channel and inflated to retain the agent.
Claim 6
Dependent Claim
24 words
The method of claim 1, wherein the step of positioning the channel forming means comprises advancing the channel forming means through the patient's chest.
Claim 7
Independent Claim
85 words
A system for treating a patient's heart, comprising: a) an elongated laser radiation transmitting and emitting means to form a channel within a wall of the patient's heart which includes a myocardial layer; and b) catheter means to deliver a therapeutic or diagnostic agent into a channel formed by the channel forming means which is disposed about the elongated laser radiation transmitting and emitting means and which has a distal end configured to fit into the channel formed in the wall of the patient's heart.
Claim 8
Independent Claim
85 words
A system for treating a patient's heart, comprising: a) an elongated laser radiation transmitting and emitting means to form a channel within a wall of the patient's heart which includes a myocardial layer; and b) catheter means to deliver a therapeutic or diagnostic agent into a channel formed by the channel forming means which is disposed about the elongated laser radiation transmitting and emitting means and which has a distal end configured to fit into the channel formed in the wall of the patient's heart.
Claim 9
Independent Claim
110 words
A system for treating a patient's heart, comprising: a) ablation means to form a channel within a wall of the patient's heart which includes a myocardial layer; b) means to deliver a therapeutic or diagnostic agent into a channel formed by the ablation means, including a catheter which has a distal end configured to fit within the channel formed by the ablation means, which has a delivery opening in the distal end and which has a lumen extending therein to the delivery opening at the distal end into which the ablation means is disposed; and c) means to increase the retention of the therapeutic or diagnostic agent within the channel.
Claim 10
Independent Claim
110 words
A system for treating a patient's heart, comprising: a) ablation means to form a channel within a wall of the patient's heart which includes a myocardial layer; b) means to deliver a therapeutic or diagnostic agent into a channel formed by the ablation means, including a catheter which has a distal end configured to fit within the channel formed by the ablation means, which has a delivery opening in the distal end and which has a lumen extending therein to the delivery opening at the distal end into which the ablation means is disposed; and c) means to increase the retention of the therapeutic or diagnostic agent within the channel.
References Cited (Backward Citations)
US5213570A
Cited
US5484384A
Cited
US5269326A
Cited
US5302706A
Cited
US5578007A
Cited
US5500012A
Cited
WO1994002838A1
Cited
US5433700A
Cited
US5431649A
Cited
US5545193A
Cited
US5571151A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-11-23 | 2002-05-25 | 2002-11-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-11-23 | 2006-05-25 | 2006-11-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-11-23 | 2010-05-25 | 2010-11-24 | $7700.00 | Window Closed / Lapsed |